ELANE and endometrial cancer: (138) measured the levels of citH3, cfDNA, cfmtDNA, which are markers of NETs, in the serum of patients with endometrial cancer and using antibodies directed against citH3, NE, and histone 2B, examined NETosis in endometrial cancer tissues.